Research Topics
Species | R ThiebautSummaryCountry: France Publications
| Collaborators
|
Detail Information
Publications
Determinants of response to first HAART regimen in antiretroviral-naïve patients with an estimated time since HIV seroconversionR Thiebaut
INSERM E0338 Biostatistics, Bordeaux 2 University, Bordeaux, France
HIV Med 7:1-9. 2006..To study the determinants of immunological and virological response to highly active antiretroviral therapy (HAART) in naïve patients, adjusting for time since HIV-1 seroconversion...
Association of soluble CD14 and inflammatory biomarkers with HIV-2 disease progressionRodolphe Thiebaut
Institut National de la Sante et de la Recherche Medicale INSERM, Institut de Santé Publique, d Epidémiologie et de Développement ISPED, Centre INSERM U897 Epidemiologie Biostatistique, Paris, France
Clin Infect Dis 55:1417-25. 2012..It is not known whether markers of inflammation such as high-sensitivity C-reactive protein (hsCRP), interleukin 6 (IL-6), and soluble CD14 (sCD14) may predict disease progression among HIV-2 patients...
Pseudomonas aeruginosa acquisition on an intensive care unit: relationship between antibiotic selective pressure and patients' environmentAlexandre Boyer
Service de Reanimation Medicale, Hopital Pellegrin Tripode, Place Amelie Raba Leon, 33076 Bordeaux Cedex, France
Crit Care 15:R55. 2011..The purpose of this study was to investigate the relationship among Pseudomonas aeruginosa acquisition on the intensive care unit (ICU), environmental contamination and antibiotic selective pressure against P. aeruginosa...
Alternative methods to analyse the impact of HIV mutations on virological response to antiviral therapyLinda Wittkop
INSERM, Unit 897, Bordeaux, France
BMC Med Res Methodol 8:68. 2008..Without pre-selection each mutation presented in at least one patient is considered with a different weight. We compared these two strategies with the construction of a usual genotypic score...
Biases in observational studies of the effect of prenatal treatment for congenital toxoplasmosisRodolphe Thiebaut
INSERM U593, Institut de Santé Publique, d Epidémiologie et de Développement ISPED, université Bordeaux 2 Victor Segalen, Bordeaux, France
Eur J Obstet Gynecol Reprod Biol 124:3-9. 2006..Given the limitations of existing observational studies and lack of randomised controlled trials, a systematic review of cohort studies offers the best approach for exploring potential biases...
Immunological markers after long-term treatment interruption in chronically HIV-1 infected patients with CD4 cell count above 400 x 10(6) cells/lRodolphe Thiebaut
INSERM E0338 and U593, ISPED, Universite Bordeaux 2, Bordeaux Cedex, France
AIDS 19:53-61. 2005..To analyse immunological markers associated with CD4+ lymphocyte T-cell count (CD4+) evolution during 12-month follow-up after treatment discontinuation...
Joint modelling of bivariate longitudinal data with informative dropout and left-censoring, with application to the evolution of CD4+ cell count and HIV RNA viral load in response to treatment of HIV infectionRodolphe Thiebaut
INSERM E0338 Biostatistics, ISPED, Universite Victor Segalen Bordeaux 2, 146 rue Leo Saignat, 33076 Bordeaux Cedex, France
Stat Med 24:65-82. 2005..We apply the model to data from patients starting antiretroviral treatment in the CASCADE collaboration where all of the three issues needed to be addressed...
Mixed models for longitudinal left-censored repeated measuresRodolphe Thiebaut
ISPED, INSERM E0338 Biostatistics, Université Victor Segalen Bordeaux II, 146, rue Leo Saignat 33076, Bordeaux Cedex, France
Comput Methods Programs Biomed 74:255-60. 2004..We show how to fit these models using SAS Proc NLMIXED and we compare this tool with other programs. Indications and limitations of the programs are discussed and an example in the field of HIV infection is shown...
Analysis of undetectable HIV RNA using survival analysis: results must be interpreted carefullyRodolphe Thiebaut
INSERM U593, Institut de Santé Publique d Epidémiologie et de Développement, Bordeaux, France
HIV Clin Trials 4:417-20. 2003..The potential for loss of information might yield differential misclassification biases and therefore unreliable results. Longitudinal models are better suited to analyze the repeated measures of a continuous outcome such as HIV RNA...
Predictors of hypertension and changes of blood pressure in HIV-infected patientsRodolphe Thiebaut
INSERM E0338 epsilont U593, ISPED, Universite Victor Segalen Bordeaux 2, Bordeaux, France
Antivir Ther 10:811-23. 2005..We assessed predictors of changes in systolic (SBP) and diastolic (DBP) blood pressure during follow-up and of the development of hypertension in HIV-infected individuals...
Bivariate linear mixed models using SAS proc MIXEDRodolphe Thiebaut
INSERM Unité 330, ISPED, Université Victor Segalen Bordeaux II, 146, rue Leo Saignat 33076, Cedex, Bordeaux, France
Comput Methods Programs Biomed 69:249-56. 2002..Limitations of this program are discussed and an example in the field of HIV infection is shown. Despite some limitations, SAS Proc MIXED is a useful tool that may be easily extendable to multivariate response in longitudinal studies...
When it is better to estimate a slope with only one pointR Thiebaut
INSERM U897 Epidemiology and Biostatistics, ISPED, Universite Victor Segalen Bordeaux 2, 146 rue Leo Saignat 33076 Bordeaux Cedex, France
QJM 101:821-4. 2008..In this short note, we explain why this could lead to imprecise and biased estimates. Furthermore, we discuss a standard statistical method that handles such issues...
Long-term nonprogressors and elite controllers in the ANRS CO5 HIV-2 cohortRodolphe Thiebaut
INSERM U, Bordeaux Segalen University, ISPED, France
AIDS 25:865-7. 2011..1% (95% confidence interval 3.9-9.1) and 9.1% (6.3-12.7), respectively. Most LTNPs (81%) were HIV controllers, whereas only 55% of HIV controllers were LTNPs...
Prevalence and factors associated with renal impairment in HIV-infected patients, ANRS C03 Aquitaine Cohort, FranceE K Déti
Institut National de la Santé et de la Recherche Médicale U897, Bordeaux, F 33076, France
HIV Med 11:308-17. 2010..The aims of the present study were to estimate the prevalence of renal impairment (RI) among HIV-infected adult patients and to investigate the associated factors...
Bacterial pneumonia among HIV-infected patients: decreased risk after tobacco smoking cessation. ANRS CO3 Aquitaine Cohort, 2000-2007Antoine Benard
INSERM, U897, CIC EC7, Bordeaux, France
PLoS ONE 5:e8896. 2010..Our objective was to estimate the effect of tobacco smoking withdrawal on the risk of bacterial pneumonia among HIV-infected individuals...
Incidence and risk factors of severe hypertriglyceridaemia in the era of highly active antiretroviral therapy: the Aquitaine Cohort, France, 1996-99R Thiebaut
Unité INSERM 330, Institut de Santé Publique, d Epidémiologie et de Développement ISPED, Universite Victor Segalen Bordeaux 2, Bordeaux, France
HIV Med 2:84-8. 2001..To estimate the incidence of serum hypertriglyceridaemia > 6 mm/L (HTG) and identify associated factors in the era of highly active antiretroviral therapy (HAART)...
Determinants of clinical progression in antiretroviral-naive HIV-infected patients starting highly active antiretroviral therapy. Aquitaine Cohort, France, 1996-2002F Bonnet
Department of Internal Medicine and Infectious Diseases, Saint Andre Hospital, Bordeaux University Hospital, Bordeaux, France
HIV Med 6:198-205. 2005..To determine the factors associated with clinical progression (AIDS events and death) in antiretroviral-naive patients who have begun highly active antiretroviral therapy (HAART)...
Trends and determinants of severe morbidity in HIV-infected patients: the ANRS CO3 Aquitaine Cohort, 2000-2004F Bonnet
CHU de Bordeaux, Services de Médecine Interne et Maladies Infectieuses, Bordeaux, France
HIV Med 8:547-54. 2007..The aim of the study was to characterize the causes, trends and determinants of severe morbidity in a large cohort of HIV-infected patients between 2000 and 2004...
Virological and immunological response in HIV-1-infected patients with multiple treatment failures receiving raltegravir and optimized background therapy, ANRS CO3 Aquitaine CohortLinda Wittkop
INSERM, Unit Epidemiology and Biostatistics, Bordeaux, France
J Antimicrob Chemother 63:1251-5. 2009..We studied viro-immunological response, pharmacokinetic parameters and genotypic test results in an observational cohort of multiple ARV class-experienced patients starting a raltegravir-based regimen...
Weight loss and body mass index as predictors of HIV disease progression to AIDS in adults. Aquitaine cohort, France, 1985-1997E Malvy
Unité INSERM 330, Universite Victor Segalen Bordeaux 2, Hĵpital Saint André, Centre Hospitalier Universitaire de Bordeaux, France
J Am Coll Nutr 20:609-15. 2001..To assess the performance of weight related nutritional markers (reported involuntary weight loss greater than 10%, measured weight loss and body mass index-BMI-) in predicting HIV disease progression...
[Epidemiology of discordant virologic and immunologic responses in HIV-1 infected patients]R Thiebaut
INSERM E0338 et INSERM U593, ISPED, Universite Bordeaux 2, Bordeaux, France
Med Mal Infect 35:S31-2. 2005
Transmission of HIV-1 minority-resistant variants and response to first-line antiretroviral therapyOlivia Peuchant
Virology Laboratory, Bordeaux University Hospital, Bordeaux, France
AIDS 22:1417-23. 2008..We investigated the clinical relevance of the detection of majority and minority-resistant variants in an observational study in antiretroviral therapy naive, recently infected patients...
Interpretation of genotype and pharmacokinetics for resistance to fosamprenavir-ritonavir-based regimens in antiretroviral-experienced patientsIsabelle Pellegrin
Department of Virology, INSERM U593, Bordeaux University Hospital, France
Antimicrob Agents Chemother 51:1473-80. 2007..Specific mutations, PK and GIQ, provide relevant information for monitoring fosamprenavir-ritonavir-based HAART...
Can highly active antiretroviral therapy be interrupted in patients with sustained moderate HIV RNA and > 400 CD4+ cells/microl? Impact on immunovirological parametersIsabelle Pellegrin
Department of Virology and Immunology, Bordeaux University Hospital, Bordeaux, France
J Med Virol 77:164-72. 2005..HIV1 DNA genotyping helps monitor patients with undetectable HIV RNA at M0...
Time-updated CD4+ T lymphocyte count and HIV RNA as major markers of disease progression in naive HIV-1-infected patients treated with a highly active antiretroviral therapy: the Aquitaine cohort, 1996-2001Rodolphe Thiebaut
Institut National de la Santé et de la Recherche Médicale Unité 330, Institut de Santé Publique, d Épidémiologie et de Développement, Universite Victor Segalen, Bordeaux, France
J Acquir Immune Defic Syndr 33:380-6. 2003..Clinical decisions and interpretation of clinical trial results must weigh the signification of each of these 2 biomarkers...
Maximum likelihood estimation in dynamical models of HIVJ Guedj
INSERM, U875 Biostatistique, Bordeaux, F 33076, France
Biometrics 63:1198-206. 2007..We apply this approach to the analysis of a clinical trial of antiretroviral therapy (ALBI ANRS 070) and we show that the whole algorithm works well in a simulation study...
Validation and comparison of simple noninvasive indexes for predicting liver fibrosis in HIV-HCV-coinfected patients: ANRS CO3 Aquitaine cohortMarc Arthur Loko
INSERM, U593, Bordeaux, France
Am J Gastroenterol 103:1973-80. 2008..Although an increasing number of noninvasive fibrosis markers are available in HCV-monoinfected patients, data on the performance of these tests in HIV-HCV-coinfected patients are lacking...
[Analysis of left-censored quantitative outcome: example of procalcitonin level]J Asselineau
Unité de Soutien Méthodologique à la Recherche Clinique et Epidémiologique, CHU de Bordeaux, ISPED, 33076 Bordeaux, France
Rev Epidemiol Sante Publique 55:213-20. 2007..Analysis of such data requires appropriate statistical techniques. In this study, we aimed at comparing various methods used to deal with left-censored outcome in regression analysis...
Factors associated with the occurrence of AIDS-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy: Aquitaine Cohort, FranceFabrice Bonnet
Service de Medecine Interne et Maladies Infectieuses, Hôpital Saint André, Bordeaux, France
Clin Infect Dis 42:411-7. 2006....
Score tests for exploring complex models: application to HIV dynamics modelsJulia Drylewicz
INSERM U897, Epidemiology and Biostatistics Research Center, Bordeaux, France
Biom J 52:10-21. 2010..We study type I errors and the statistical powers of this score test statistics and we apply the score test approach to a real data set of HIV-infected patients...
Virological response to darunavir/ritonavir-based regimens in antiretroviral-experienced patients (PREDIZISTA study)Isabelle Pellegrin
Department of Virology, Bordeaux University Hospital, Bordeaux, France
Antivir Ther 13:271-9. 2008....
Bivariate longitudinal model for the analysis of the evolution of HIV RNA and CD4 cell count in HIV infection taking into account left censoring of HIV RNA measuresRodolphe Thiebaut
INSERM EMI 0338, Institut de Santé Publique d Épidémiologie et de Développement ISPED, Universite Victor Segalen Bordeaux 2, Bordeaux, France
J Biopharm Stat 13:271-82. 2003..Despite some limitations (distribution assumption, ignorance of missingness process), such a model appeared to be very useful to correctly describe the current evolution of important biomarkers in HIV infection...
Practical identifiability of HIV dynamics modelsJ Guedj
INSERM, U875 Biostatistique, Bordeaux, 33076, France
Bull Math Biol 69:2493-513. 2007....
CD4+ T-lymphocytes natural decrease in HAART-naïve HIV-infected adults in AbidjanJ Duvignac
INSERM U593, Bordeaux, France
HIV Clin Trials 9:26-35. 2008..To study the CD4 natural decrease and its determinants in sub-Saharan African HIV-infected adults...
Determinants of smoking cessation attempts among HIV-infected patients results from a hospital-based prospective cohortGaelle Encrenaz
INSERM, U897, CIC EC7, Bordeaux, F 33076 France
Curr HIV Res 8:212-7. 2010..Tobacco smoking is a major modifiable risk factor of these emergent conditions and almost half of these patients are regular smokers in resource-rich countries...
Methodological issues in the use of composite endpoints in clinical trials: examples from the HIV fieldLinda Wittkop
INSERM U897, Research Centre for Epidemiology and Biostatistics, Bordeaux, France
Clin Trials 7:19-35. 2010..g. rapid virological suppression) or the licensing requirements of official drug approval organizations (e.g. time to loss of virological response [TLOVR])...
Comparison of early CD4 T-cell count in HIV-1 seroconverters in Côte d'Ivoire and France: the ANRS PRIMO-CI and SEROCO cohortsCharlotte Lewden
INSERM, U897, Bordeaux, France
J Acquir Immune Defic Syndr 53:260-5. 2010..We compared CD4+ decline among untreated HIV-1-infected seroconverters living in Côte d'Ivoire (CI) and in France...
HIV type-1 transmission dynamics in recent seroconverters: relationship with transmission of drug resistance and viral diversityPatricia Recordon-Pinson
CHU de Bordeaux, Laboratoire de Virologie, and Université Victor Segalen Bordeaux 2, Bordeaux, France
Antivir Ther 14:551-6. 2009..We investigated the relationship between the dynamics of HIV-1 transmission within recently infected patients, the HIV-1 variability and the transmission of antiretroviral drug resistance...
Evolution of 2-long terminal repeat (2-LTR) episomal HIV-1 DNA in raltegravir-treated patients and in in vitro infected cellsSandrine Reigadas
Laboratory of Virology, EA2968, University of Bordeaux 2, Bordeaux, France
J Antimicrob Chemother 65:434-7. 2010..Our aim was to analyse the evolution of HIV-1 2-long terminal repeat (2-LTR) circular DNA in vitro and ex vivo in the presence of raltegravir...
Options for clinical trials of pre and post-natal treatments for congenital toxoplasmosisGenevieve Chene
INSERM U897 Epidemiology and Biostatistics, Bordeaux School of Public Health, Bordeaux University, Bordeaux, France
Mem Inst Oswaldo Cruz 104:299-304. 2009....
Estimation of dynamical model parameters taking into account undetectable marker valuesRodolphe Thiebaut
INSERM E0338 Biostatistics, Bordeaux 2 University, Bordeaux, France
BMC Med Res Methodol 6:38. 2006..A method is proposed to take into account left-censored values for estimating parameters of non linear mixed models and its impact is demonstrated through a simulation study and an actual clinical trial of anti-HCV drugs...
Virological response to HIV-1 nucleoside/nucleotide reverse transcriptase inhibitors-based, tenofovir DF-including regimens in the ANRS Aquitaine CohortEric Balestre
INSERM U593, , Bordeaux, France
J Clin Virol 36:95-9. 2006..CONCLUSION: NRTI-based, TDF-including therapies can lead to high rates of VF both in ARV-naïve and in ARV-experienced patients. Our data strongly suggest the interest of associating ZDV and TDF in these regimens...
Effectiveness of disease-management programs for improving diabetes care: a meta-analysisClément Pimouguet
Institut National de la Sante et de la Recherche Medicale, Bordeaux, France
CMAJ 183:E115-27. 2011....
[Epidemiology of atherosclerotic cardiovascular risk in HIV-1 infected patients]R Thiebaut
Institut de Santé Publique, d Épidémiologie et de Développement, INSERM U593, Universite Victor Segalen, Bordeaux 33
Presse Med 32:1419-26. 2003..The main risk factors seem to be classical risk factors such as smoking habits, age and dyslipidemia that are partly due themselves to highly active antiretroviral treatments..
[Joint modeling of quantitative longitudinal data and censored survival time]H Jacqmin-Gadda
INSERM E 0338, Université Victor Segalen Bordeaux II, Case 11, 146, rue Leo Saignat, 33076 Bordeaux Cedex, France
Rev Epidemiol Sante Publique 52:502-10. 2004..Such models allow, for example, to perform survival analysis when a time-dependent explanatory variable is measured intermittently, or to study the evolution of a quantitative marker conditionally to an event...
Change in atherosclerosis progression in HIV-infected patients: ANRS Aquitaine Cohort, 1999-2004Rodolphe Thiebaut
INSERM EMI 0338, ISPED, Universite Victor Segalen Bordeaux 2, 33076 Bordeaux, France
AIDS 19:729-31. 2005..The progression of atherosclerosis in HIV-infected patients can be controlled. The impact of individual measures to reduce the cardiovascular risk should be evaluated further...
Change in T-lymphocyte count after initiation of highly active antiretroviral therapy in HIV-infected patients with history of Mycobacterium avium complex infectionEstibaliz Lazaro
Department of Internal Medicine and Infectious Diseases, Bordeaux University Hospital, Bordeaux, France
Antivir Ther 11:343-50. 2006..A better understanding of the underlying mechanism and an evaluation of additional treatment strategies are necessary to help immune restoration in such circumstances...
Effectiveness of prenatal treatment for congenital toxoplasmosis: a meta-analysis of individual patients' dataRodolphe Thiebaut
INSERM, Bordeaux, France
Lancet 369:115-22. 2007..Despite three decades of prenatal screening for congenital toxoplasmosis in some European countries, uncertainty remains about the effectiveness of prenatal treatment...
Pravastatin in HIV-infected patients treated with protease inhibitors: a placebo-controlled randomized studyFabrice Bonnet
Service de Medecine Interne et Maladies Infectieuses, Hôpital Saint André, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France
HIV Clin Trials 8:53-60. 2007..5 mmol/L...
Evidence that an identical T cell clone in skin and peripheral blood lymphocytes is an independent prognostic factor in primary cutaneous T cell lymphomasM Beylot-Barry
Equipe Histologie et Pathologie Moléculaire 12406, Universite Victor Segalen Bordeaux 2, France
J Invest Dermatol 117:920-6. 2001..A fully prospective study, with simultaneous therapeutic trials, needs to be done to confirm our findings and to include treatment variables in the statistical analysis...
Reduced bone mineral density in HIV-infected patients: prevalence and associated factorsCharles Cazanave
Fédération de maladies infectieuses et tropicales, Hopital Pellegrin, Place A, Raba Léon, 33076 Bordeaux Cedex, France
AIDS 22:395-402. 2008..There is a high prevalence of bone demineralization among HIV-infected patients but mechanisms of alteration of bone turnover are still unclear and it is thought to be multifactorial...
Non-AIDS-defining deaths and immunodeficiency in the era of combination antiretroviral therapyBenoit Marin
INSERM, U897, Bordeaux, France
AIDS 23:1743-53. 2009..To assess whether immunodeficiency is associated with the most frequent non-AIDS-defining causes of death in the era of combination antiretroviral therapy (cART)...
TNFSF15 polymorphisms are associated with susceptibility to inflammatory bowel disease in a new European cohortR Thiebaut
INSERM, U843, Hopital Robert Debre, Universite Paris Diderot, Paris, France
Am J Gastroenterol 104:384-91. 2009..This replication study was designed in order to confirm and further validate the role of TNFSF15 in IBD...
Prevalence and occupational covariates of mood, anxiety disorders, and alcohol dependence in a French ancillary staff populationR Thiebaut
Département d information médicale, Universite Victor Segalen Bordeaux 2, 146, rue Leo Saignat, CH Charles Perrens France
Eur Psychiatry 14:210-6. 1999....
Prediction of cytomegalovirus (CMV) plasma load from evaluation of CMV whole-blood load in samples from renal transplant recipientsIsabelle Garrigue
Universite Victor Segalen Bordeaux 2, Laboratoire de Virologie EA2968, 146 rue Leo Saignat, 33 076 Bordeaux Cedex, France
J Clin Microbiol 46:493-8. 2008..WB seems to be an appropriate candidate for routine CMV monitoring of transplant recipients by using a single assay...
Effectiveness of health education on Toxoplasma-related knowledge, behaviour, and risk of seroconversion in pregnancyERICA L GOLLUB
INSERM, U593, Bordeaux, Universite Victor Segalen Bordeaux 2, Institut de Santé Publique, d Épidémiologie et de Développement, Bordeaux, F 33076 Bordeaux cedex, France
Eur J Obstet Gynecol Reprod Biol 136:137-45. 2008..There is suggestive evidence that health education approaches may help reduce risk of congenital toxoplasmosis but this problem requires further study using more rigorous research design and methodology...
Behavioral audiometry: validity of audiometric measurements obtained using the "Delaroche protocol" in babies aged 4--18 months suffering from bilateral sensorineural hearing lossMonique Delaroche
Pediatric Audiology Unit, CHU Pellegrin, Bordeaux, France
Int J Pediatr Otorhinolaryngol 70:993-1002. 2006....
Decrease in circulating dendritic cells predicts fatal outcome in septic shockOlivier Guisset
Département de Réanimation Médicale et Urgences, Hôpital St André, CHU de Bordeaux, Bordeaux, France
Intensive Care Med 33:148-52. 2007..Experimental models of septic shock in mouse previously noted a decrease in dendritic cell numbers. The aim of the study was to find a rapid reproducible biological test for an assessment of disease severity...
